Healthtech Startups

Thryv Therapeutics is a clinical-stage biotechnology company developing selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1) for inherited cardiac arrhythmias such as Long QT Syndrome and acquired cardiometabolic diseases. Its lead compound, THRV-1268, is in a Phase 2/3 clinical study for Long QT Syndrome Type 2.

1 investor

LSL Healthcare supplies medical products and customized kits to healthcare providers, sourcing from ISO 9000-certified manufacturers and offering a supply chain with alternative sourcing during shortages. The company distributes to healthcare facilities across the US and Canada.

1 investor

LTL Pharma acquires and develops long-established pharmaceutical drugs (long-life medications) from originator manufacturers, maintaining consistent supply and quality standards for healthcare providers and patients. The company specializes in managing mature pharmaceutical products with extensive clinical track records.

1 investor

LTZ Therapeutics is an immunotherapy biotech developing treatments for oncology and autoimmune diseases using a myeloid cell engager approach centered on macrophages. It operates a Myeloid Engager Platform and has entered development collaborations with large pharmaceutical companies.

1 investor

LUBU makes smart insoles with built-in sensors that capture movement biomechanics and kinetic data to predict injury and track recovery for athletes, military personnel, and patients. The company uses proprietary hardware and AI-driven analysis, drawing on seventy years of footwear manufacturing expertise, to provide lab-grade movement measurement at scale.

1 investor

Luca develops LucaPlex, a modular SaaS platform combining digital biomarkers, AI algorithms, wearable devices, ePRO, and remote patient management to help life science companies and healthcare institutions build digital medicine products. The platform supports clinical trials, drug development, insurance and employee wellness programs by collecting continuous physiological and behavioral health data.

1 investor

Luca Health is a clinician-led platform for managing concussions in schools and sports clubs, covering the full process from logging an incident to a clinically supervised return to sport. It provides clinical review via secure video consultation, baseline neurocognitive testing, recovery tracking, documentation, and training modules, built around its evidence-based Luca Safe Concussion Framework and oriented to UK regulatory requirements.

1 investor

Lucem Health applies clinical artificial intelligence to help healthcare providers detect chronic diseases earlier in patients. The company develops AI-driven platforms for healthcare systems to improve disease detection and patient outcomes.

1 investor

Lucid Diagnostics develops tests for the early detection of esophageal precancer using targeted next-generation sequencing, aimed at helping clinicians detect and treat the condition before it progresses to cancer. The company operates a CLIA-certified, CAP-accredited clinical lab licensed by the New York State Department of Health.

1 investor

LucidHealth is a physician-led healthcare organization that supports a national network of radiology practices across the United States through corporate services including operations, finance, technology, and strategy. The company focuses on empowering radiologists and advancing clinical outcomes in radiology care.

1 investor

Lucor builds explainable AI that helps health-plan investigators detect and triage fraud, waste, and abuse in claims.

1 investor

LucyRx is a pharmacy benefit manager (PBM) that provides transparent pricing, clinical guidance, and AI-powered pharmacy intelligence to health plan sponsors and their members. The company serves commercial and government health plans through a network of over 60,000 pharmacies, utilizing its proprietary LucyIQ analytics platform and clinical care guides to reduce drug costs and improve prescription outcomes.

1 investor

Spreo is a visual collaboration platform for team planning, meetings, and retrospectives, used by agile teams, coaches, engineers, product owners, and designers. It offers shared visual spaces, action tracking with Jira integration, anonymous input, and templates to keep teams aligned on shared goals.

1 investor

LumaBridge is an oncology-focused contract research organization (CRO) that supports outsourced clinical trials, offering services such as regulatory affairs, clinical operations, data management, medical writing, and biostatistics. It serves emerging biopharma and biotech companies developing novel oncology and immunotherapy treatments.

1 investor

Lume provides a platform that integrates coaching, health insights, and data systems to support founder performance and well-being. The platform serves founders building startups, combining professional coaching and health optimization to improve sustainable high performance.

1 investor

Lume develops a wearable sweat sensor that monitors hormonal changes and health metrics throughout the day. The device is designed for individuals seeking continuous health insights beyond traditional periodic checkups.

1 investor

Lumed develops expert software systems for hospitals that support clinical practices, aiming to improve patient care and prevent healthcare-associated (nosocomial) infections. It serves hospitals in the healthcare sector.

1 investor

Lumen develops orally delivered antibody drugs using engineered spirulina, a patented biologic platform that reduces manufacturing costs and timelines compared to conventional biologics. The company serves biopharma customers seeking alternatives to traditional drug manufacturing.

1 investor

Lumena Pharmaceuticals develops pharmaceutical, nutraceutical, and testing service products using biotechnology, with a focus on ethical practices in research, manufacturing, and distribution across health care markets. The company prioritizes environmental sustainability, reduced chemical use, and responsible innovation in bioavailable product development.

1 investor

Lumenate Medical is developing a catheter-based cystoscope designed for non-urologist providers such as Physician Associates and Nurse Practitioners to perform bladder cancer screening with specialist oversight. The device aims to expand access to early bladder cancer diagnosis by capturing the images urologists need without requiring a urologist in the room.

1 investor

Lumenis develops and commercializes energy-based medical devices for the aesthetics and vision markets, serving healthcare professionals worldwide. The company holds over 330 patents and numerous FDA clearances, with an installed base of more than 80,000 systems across over 100 countries.

1 investor

InvolveXR offers an AI-enabled virtual reality training platform for healthcare education that combines immersive simulations with AI-assisted assessments to help institutions scale personalized learning and clinical skill development.

1 investor

LUMEUS develops digital mental health training programs based on the Herzog Method for children and adults, offering emotional wellness and stress management courses delivered through an app and online platform.

1 investor

Lumia Care operates a healthcare conglomerate that provides aged care, disability support, hospital-level in-home care, and nursing workforce services across Australia. The company serves individuals, families, and healthcare institutions seeking personalized and clinical care services to support independence and wellbeing.

1 investor